Imagion Biosystems Limited

IBXXFOTCHealthcare● Active

$0.03

+$0.00(+0.00%)

Market Cap$6626738

P/E Ratio—

52W High$0.04

52W Low$0.008

Avg Volume4K

Open$0.02

Beta-0.21

Overview

Imagion Biosystems Limited (IBXXF) Earnings: Dates, EPS & Revenue History

Quarterly EPS vs. estimates, revenue surprises, next earnings date, and analyst consensus.

IBXXF · earnings · updated Jun 15, 2026

Latest Earnings

Q1 FY2026Report Date: Feb 26, 2026

EPS Actual

-$0.00

Revenue

—

Fiscal Period

Q1 FY2026

FY ends December

Report Date

Feb 26, 2026

After Market Close

IBXXF reports quarterly as a OTC-listed Medical - Diagnostics & Research company. Fiscal year ends in December. Data: FMP · Updated hourly.

Next Earnings Date

Days Away

days

Expected Date

Sep 2, 2026

Fiscal Period

Q3 FY2026

Release Time

◌ Time TBD (Unconfirmed)

EPS Est.

—

Days Away79

Expected DateSep 2, 2026

Fiscal PeriodQ3 FY2026

Release TimeTime TBD (Unconfirmed)

EPS Est.—

EPS & Revenue vs. Estimates

Actual (Beat)

Actual (Miss)

Estimated

Earnings History

Period	Report Date	EPS Est.	EPS Actual	EPS Surpr.	Revenue	Rev. Est.	Rev. Surpr.
— Q1 FY2026	Feb 26, 2026	—	-$0.00	—	—	—	—
— Q3 FY2025	Sep 1, 2025	—	-$0.01	—	$0.00B	—	—
◌ Q2 FY2025	May 30, 2025	—	—	—	—	—	—
— Q1 FY2025	Mar 24, 2025	—	-$0.01	—	$0.00B	—	—
◌ Q4 FY2024	Oct 28, 2024	—	—	—	—	—	—
— Q3 FY2024	Aug 30, 2024	—	-$0.03	—	$0.00B	—	—
◌ Q2 FY2024	Apr 30, 2024	—	—	—	—	—	—
— Q1 FY2024	Feb 29, 2024	—	-$0.10	—	$0.00B	—	—

Q1 FY2026

Feb 26, 2026

EPS Actual

-$0.00

EPS Est.

—

EPS Surpr.

—

Revenue

—

Q3 FY2025

Sep 1, 2025

EPS Actual

-$0.01

EPS Est.

—

EPS Surpr.

—

Revenue

$0.00B

Q2 FY2025

May 30, 2025

EPS Actual

—

EPS Est.

—

EPS Surpr.

—

Revenue

—

Q1 FY2025

Mar 24, 2025

EPS Actual

-$0.01

EPS Est.

—

EPS Surpr.

—

Revenue

$0.00B

Q4 FY2024

Oct 28, 2024

EPS Actual

—

EPS Est.

—

EPS Surpr.

—

Revenue

—

Q3 FY2024

Aug 30, 2024

EPS Actual

-$0.03

EPS Est.

—

EPS Surpr.

—

Revenue

$0.00B

Q2 FY2024

Apr 30, 2024

EPS Actual

—

EPS Est.

—

EPS Surpr.

—

Revenue

—

Q1 FY2024

Feb 29, 2024

EPS Actual

-$0.10

EPS Est.

—

EPS Surpr.

—

Revenue

$0.00B

No analyst estimates available for IBXXF.

Earnings Price Reaction

Closing price one trading day before vs. one trading day after each earnings release.

Period	Report Date	EPS Beat/Miss	Price Before	Price After	1D Reaction
— Q1 FY2026	Feb 26, 2026	—	$0.01	$0.01	+30.00%
— Q3 FY2025	Sep 1, 2025	—	$0.02	$0.02	+0.00%
— Q1 FY2025	Mar 24, 2025	—	$0.01	$0.01	+0.00%
— Q3 FY2024	Aug 30, 2024	—	$0.04	$0.04	+0.00%
— Q1 FY2024	Feb 29, 2024	—	$0.26	$0.26	+0.00%
— Q2 FY2023	Jun 30, 2023	—	$0.40	$0.40	+0.00%
— Q1 FY2023	Mar 31, 2023	—	$0.16	$0.16	+0.00%
— Q4 FY2022	Dec 31, 2022	—	$4.00	$4.00	+0.00%

Q1 FY2026+30.00%

Report Date

Feb 26, 2026

EPS Beat/Miss

—

Price Before

$0.01

Price After

$0.01

Q3 FY2025+0.00%

Report Date

Sep 1, 2025

EPS Beat/Miss

—

Price Before

$0.02

Price After

$0.02

Q1 FY2025+0.00%

Report Date

Mar 24, 2025

EPS Beat/Miss

—

Price Before

$0.01

Price After

$0.01

Q3 FY2024+0.00%

Report Date

Aug 30, 2024

EPS Beat/Miss

—

Price Before

$0.04

Price After

$0.04

Q1 FY2024+0.00%

Report Date

Feb 29, 2024

EPS Beat/Miss

—

Price Before

$0.26

Price After

$0.26

Q2 FY2023+0.00%

Report Date

Jun 30, 2023

EPS Beat/Miss

—

Price Before

$0.40

Price After

$0.40

Q1 FY2023+0.00%

Report Date

Mar 31, 2023

EPS Beat/Miss

—

Price Before

$0.16

Price After

$0.16

Q4 FY2022+0.00%

Report Date

Dec 31, 2022

EPS Beat/Miss

—

Price Before

$4.00

Price After

$4.00

Beat Rate0 / 8 quarters

Largest Move+30.00% (Q1 FY2026)

Data: FMP /historical-price-eod/full · field: close

About Earnings & Data Methodology

Imagion Biosystems Limited (IBXXF) most recently reported earnings on February 26, 2026 for Q1 FY2026, posting EPS of $-0.00 (in line with the analyst consensus of —). The next IBXXF earnings date is expected around September 2, 2026.

Each quarter, investors track IBXXF earnings for signals on forward guidance and business momentum. For longer-term revenue trends, see the Revenue tab. IBXXF revenue tab →

Earnings Glossary

EPS (Earnings Per Share)

Net income ÷ diluted shares outstanding. The primary metric analysts use to gauge quarterly profitability.

Earnings Surprise %

(Actual − Estimate) / |Estimate| × 100. Positive = Beat. Negative = Miss.

Beat / Miss / In-Line

Beat = Actual ≥ Estimate. Miss = Actual < Estimate. In-Line = within ±1%.

BMO / AMC

Before Market Open / After Market Close. Two windows when companies typically release results.

Fiscal Quarter

IBXXF's fiscal year ends in December. Fiscal quarters may not align with calendar quarters.

Analyst Consensus

Average EPS/Revenue forecast across all covering analysts. More analysts = more reliable estimate.

Figures tie to FMP earnings calendar, estimates, and SEC 10-Q/10-K filings where noted.

Revenue Price history Financial statements Forecast Dividends Market cap

Frequently asked questions

IBXXF earnings · 4 questions

Imagion Biosystems Limited's next earnings report is expected around September 2, 2026. IBXXF typically reports quarterly — approximately every three months. The exact date is confirmed by the company 2–4 weeks before the release. Time is currently TBD; IBXXF historically reports after market close (AMC).

IBXXF earnings datewhen is IBXXF earningsIBXXF next earnings datewhen does IBXXF report earningsIBXXF earnings calendar

▸ Source: FMP · Imagion Biosystems Limited SEC filings · US GAAP · Imagion Biosystems Limited SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 15, 2026